Literature DB >> 26315608

ADNP/ADNP2 expression in oligodendrocytes: implication for myelin-related neurodevelopment.

Anna Malishkevich1, Janina Leyk2, Olaf Goldbaum2, Christiane Richter-Landsberg2, Illana Gozes3.   

Abstract

Oligodendrocytes, the myelin-forming cells of the central nervous system, play important roles in brain development and maintenance. Activity-dependent neuroprotective protein (ADNP), an early marker essential for brain formation, interacts with microtubule end-binding proteins (EB1, EB2, and EB3). EB1 and EB3 are highly expressed in neurons (axons and dendritic spines, respectively) and EB1 enhancement of neurite outgrowth is attenuated by EB2. ADNP/EB presence in oligodendrocytes has not been studied so far. Here, we measured messenger RNA (mRNA) levels of ADNP and EB1-EB3 in rat brain oligodendrocytes during culture maturation and in rat brains during development (1, 35, and 75 days) in comparison with rat astrocytes, dorsal root ganglion (DRG) neurons, and the oligodendroglia cell lines (OLN-93 cell line, not expressing the microtubule-associated protein (MAP) tau, and OLN-93 cells stably transfected to express various forms of tau). Results showed that all transcripts studied were expressed in oligodendrocytes. ADNP and EB2 mRNA transcript content peaked at the time of oligodendrocyte maturation (5 days in vitro) and was highest in newborn rat brains compared with mature brains. ADNP2 (the only family member of ADNP), and EB1, although expressed in lower quantities, essentially paralleled ADNP and EB2 expression patterns, respectively. EB3 mRNA, peaking upon oligodendrocyte maturation, showed an apparent second peak of expression (10 days in vitro) and increased in the mature rat brain compared with the newborn brain. DRG cells expressed the highest levels of EB3, when compared with oligodendrocyte precursors and with astrocytes but not when compared with mature oligodendrocytes. Mature oligodendrocytes and oligodendrocyte precursors expressed ~30-40-fold more EB2 vs. EB3, and ~4-7-fold vs. ADNP. DRGs expressed ~5-fold more EB2 vs. EB3 and astrocytes showed an in-between (~20-fold) ratio. Only DRGs expressed similar EB1 and EB3 transcript levels, contrasting with oligodendrocyte and astrocytes (~10-30-fold more EB1). Astrocytes expressed more ADNP than DRGs and oligodendrocyte precursor cells (~2-fold) but not compared with mature oligodendrocytes. EB1 and EB3 were previously found to be associated with tau. Immortalized oligodendrocytes showed an intermediate phenotype of mRNA expression compared with oligodendrocyte precursor cells and mature oligodendrocytes with tau transfection reducing overall ADNP and EB expression. In summary, ADNPs and EBs are highly expressed in oligodendrocytes suggesting an impact on myelin formation in health and disease.

Entities:  

Keywords:  Activity-dependent neuroprotective protein (ADNP); Microtubule end binding proteins (EBs); Oligodendrocytes; RNA

Mesh:

Substances:

Year:  2015        PMID: 26315608     DOI: 10.1007/s12031-015-0640-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  63 in total

1.  Visualization of microtubule growth in cultured neurons via the use of EB3-GFP (end-binding protein 3-green fluorescent protein).

Authors:  Tatiana Stepanova; Jenny Slemmer; Casper C Hoogenraad; Gideon Lansbergen; Bjorn Dortland; Chris I De Zeeuw; Frank Grosveld; Gert van Cappellen; Anna Akhmanova; Niels Galjart
Journal:  J Neurosci       Date:  2003-04-01       Impact factor: 6.167

Review 2.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

3.  Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes.

Authors:  R Müller; M Heinrich; S Heck; D Blohm; C Richter-Landsberg
Journal:  Cell Tissue Res       Date:  1997-05       Impact factor: 5.249

4.  The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey--ADNP Mutation.

Authors:  Illana Gozes; Celine Helsmoortel; Geert Vandeweyer; Nathalie Van der Aa; Frank Kooy; Sandra Bedrosian-Sermone
Journal:  J Mol Neurosci       Date:  2015-08       Impact factor: 3.444

5.  Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.

Authors:  Efrat Dresner; Galila Agam; Illana Gozes
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-03       Impact factor: 4.600

Review 6.  A neurobiological basis for substance abuse comorbidity in schizophrenia.

Authors:  R A Chambers; J H Krystal; D W Self
Journal:  Biol Psychiatry       Date:  2001-07-15       Impact factor: 13.382

7.  Cloning and characterization of the human activity-dependent neuroprotective protein.

Authors:  R Zamostiano; A Pinhasov; E Gelber; R A Steingart; E Seroussi; E Giladi; M Bassan; Y Wollman; H J Eyre; J C Mulley; D E Brenneman; I Gozes
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes.

Authors:  Sharon Furman; Ruth A Steingart; Shmuel Mandel; Janet M Hauser; Douglas E Brenneman; Illana Gozes
Journal:  Neuron Glia Biol       Date:  2004-08

9.  ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance.

Authors:  Shmuel Mandel; Irit Spivak-Pohis; Illana Gozes
Journal:  J Mol Neurosci       Date:  2008-02-20       Impact factor: 3.444

10.  Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.

Authors:  A Malishkevich; N Amram; G Hacohen-Kleiman; I Magen; E Giladi; I Gozes
Journal:  Transl Psychiatry       Date:  2015-02-03       Impact factor: 6.222

View more
  5 in total

1.  ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.

Authors:  Y Ivashko-Pachima; C Laura Sayas; A Malishkevich; I Gozes
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

2.  ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging.

Authors:  Oxana Kapitansky; Illana Gozes
Journal:  Geroscience       Date:  2019-07-01       Impact factor: 7.713

3.  Autism-associated miR-873 regulates ARID1B, SHANK3 and NRXN2 involved in neurodevelopment.

Authors:  Jing Lu; Yan Zhu; Sarah Williams; Michelle Watts; Mary A Tonta; Harold A Coleman; Helena C Parkington; Charles Claudianos
Journal:  Transl Psychiatry       Date:  2020-12-01       Impact factor: 6.222

4.  Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.

Authors:  Anke Van Dijck; Anneke T Vulto-van Silfhout; Elisa Cappuyns; Ilse M van der Werf; Grazia M Mancini; Andreas Tzschach; Raphael Bernier; Illana Gozes; Evan E Eichler; Corrado Romano; Anna Lindstrand; Ann Nordgren; Malin Kvarnung; Tjitske Kleefstra; Bert B A de Vries; Sébastien Küry; Jill A Rosenfeld; Marije E Meuwissen; Geert Vandeweyer; R Frank Kooy
Journal:  Biol Psychiatry       Date:  2018-03-15       Impact factor: 13.382

5.  Characterization of Lgr5+ Progenitor Cell Transcriptomes after Neomycin Injury in the Neonatal Mouse Cochlea.

Authors:  Shasha Zhang; Yuan Zhang; Pengfei Yu; Yao Hu; Han Zhou; Lingna Guo; Xiaochen Xu; Xiaocheng Zhu; Muhammad Waqas; Jieyu Qi; Xiaoli Zhang; Yan Liu; Fangyi Chen; Mingliang Tang; Xiaoyun Qian; Haibo Shi; Xia Gao; Renjie Chai
Journal:  Front Mol Neurosci       Date:  2017-07-04       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.